LAPTM4B and nonpapillary renal cell carcinoma: Our results (Figure 1C) showed that LAPTM4B is highly expressed in Fuhrman III/IV ccRCC tissues and are reduced in Fuhrman I/II ccRCC tissues, suggesting the phenomenon to possibly be related to the heterogeneity of renal cancer.